BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5727481)

  • 21. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
    Winand R
    Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
    Mertz DP; Stelzer M
    Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
    [No Abstract]   [Full Text] [Related]  

  • 24. [LATS in Graves-Basedow disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1971; 46(3):315-21. PubMed ID: 5108058
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 27. THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE.
    PINCHERA A; PINCHERA MG; STANBURY JB
    J Clin Endocrinol Metab; 1965 Feb; 25():189-208. PubMed ID: 14264241
    [No Abstract]   [Full Text] [Related]  

  • 28. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis.
    Hetzel BS; Mason EK; Wang HK
    Australas Ann Med; 1968 Nov; 17(4):307-11. PubMed ID: 4178378
    [No Abstract]   [Full Text] [Related]  

  • 30. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 31. LATS and recurrent thyrotoxicosis after subtotal thyroidectomy.
    Hedley AJ; Ross IP; Beck JS; Donald D; Recht FA; Michie W; Crooks J
    Clin Sci; 1970 Sep; 39(3):10P. PubMed ID: 5459149
    [No Abstract]   [Full Text] [Related]  

  • 32. [Para-neoplastic hyperthyroidism with elevated plasmatic T.S.H].
    Codaccioni JL; Jaquet P
    Ann Endocrinol (Paris); 1971; 52(4):553-6. PubMed ID: 5139434
    [No Abstract]   [Full Text] [Related]  

  • 33. Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation.
    Werner SC; Feind CR; Aida M
    N Engl J Med; 1967 Jan; 276(3):132-8. PubMed ID: 6071187
    [No Abstract]   [Full Text] [Related]  

  • 34. The bioassay of long-acting thyroid stimulator: a comparison of two methods.
    Ensor JM; Kendall-Taylor P; Munro DS; Smith BR
    J Endocrinol; 1971 Mar; 49(3):487-92. PubMed ID: 5090899
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
    Lamberg BA; Gordin A; Viherkoski M; Kvist G
    Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the treatment of hyperthyroidism with Iodine-131.
    Torizuka K; Mori T; Konishi J; Morita R; Hamamoto K; Kusakabe T; Miyake T; Fukase M
    J Nucl Med; 1967 May; 8(5):335. PubMed ID: 6032620
    [No Abstract]   [Full Text] [Related]  

  • 37. L.A.T.S. and Graves' disease.
    Hedley AJ; Ross IP; Crooks J
    Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
    [No Abstract]   [Full Text] [Related]  

  • 38. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 39. Placental transmission of thyroid-stimulating immunoglobulins.
    Dirmikis SM; Munro DS
    Br Med J; 1975 Jun; 2(5972):665-6. PubMed ID: 1173561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting thyroid stimulator in thyrotoxic monozygous twins.
    Priest WM
    Br Med J; 1970 Jul; 3(5716):205. PubMed ID: 5311030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.